PBSV · Pharma-Bio Serv, Inc. · Financials
4 customers — 55.8% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, aggregate revenues from these global group of affiliated companies were 18.6%, 17.9%, 13.8% and 5.5%, or a total of 55.8%”
4 customers — 53.6% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, aggregate revenues from these global groups of affiliated companies were 23.8%, 22.8%, 6.4% and 0.6%, or a total of 53.6%”
4 customers — 52.6% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, revenues from these customers were 18.6%, 14.7%, 13.8% and 5.5%, or a total of 52.6%”
4 customers — 49.1% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, revenues from these customers were 23.8%, 18.3%, 6.4% and 0.6%, or a total of 49.1%”
One customer — 23.8% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, revenues from these customers were 23.8%, 18.3%, 6.4% and 0.6%, or a total of 49.1%”
One customer — 23.8% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, aggregate revenues from these global groups of affiliated companies were 23.8%, 22.8%, 6.4% and 0.6%, or a total of 53.6%”
One customer — 22.8% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, aggregate revenues from these global groups of affiliated companies were 23.8%, 22.8%, 6.4% and 0.6%, or a total of 53.6%”
One customer — 18.6% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, revenues from these customers were 18.6%, 14.7%, 13.8% and 5.5%, or a total of 52.6%”
One customer — 18.6% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, aggregate revenues from these global group of affiliated companies were 18.6%, 17.9%, 13.8% and 5.5%, or a total of 55.8%”
One customer — 18.3% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, revenues from these customers were 23.8%, 18.3%, 6.4% and 0.6%, or a total of 49.1%”
One customer — 17.9% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, aggregate revenues from these global group of affiliated companies were 18.6%, 17.9%, 13.8% and 5.5%, or a total of 55.8%”
One customer — 14.7% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, revenues from these customers were 18.6%, 14.7%, 13.8% and 5.5%, or a total of 52.6%”
One customer — 13.8% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, revenues from these customers were 18.6%, 14.7%, 13.8% and 5.5%, or a total of 52.6%”
One customer — 13.8% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, aggregate revenues from these global group of affiliated companies were 18.6%, 17.9%, 13.8% and 5.5%, or a total of 55.8%”
One customer — 6.4% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, aggregate revenues from these global groups of affiliated companies were 23.8%, 22.8%, 6.4% and 0.6%, or a total of 53.6%”
One customer — 6.4% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, revenues from these customers were 23.8%, 18.3%, 6.4% and 0.6%, or a total of 49.1%”
One customer — 5.5% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, aggregate revenues from these global group of affiliated companies were 18.6%, 17.9%, 13.8% and 5.5%, or a total of 55.8%”
One customer — 5.5% of revenue (the nine months ended July 31, 2026)
“During the nine months ended July 31, 2026, revenues from these customers were 18.6%, 14.7%, 13.8% and 5.5%, or a total of 52.6%”
One customer — 0.6% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, aggregate revenues from these global groups of affiliated companies were 23.8%, 22.8%, 6.4% and 0.6%, or a total of 53.6%”
One customer — 0.6% of revenue (the three months ended July 31, 2026)
“During the three months ended July 31, 2026, revenues from these customers were 23.8%, 18.3%, 6.4% and 0.6%, or a total of 49.1%”
4 customers — 44.5% of receivables (July 31, 2026)
“On July 31, 2026, amounts due from these customers represented 44.5% of the Company's total accounts receivable balance.”
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $9.48M | $9M | $9.51M | $16.98M | $19.4M | $20.12M | $21.56M | $19.51M | $17.8M | $13.3M | — | — | — | — | — | — | — | |
| $6.42M | $6.09M | $6.99M | $11.91M | $14.52M | $14.76M | $14.9M | $13.33M | $12.11M | $9.46M | — | — | — | — | — | — | — | |
| $3.07M | $2.91M | $2.52M | $5.07M | $4.88M | $5.36M | $6.67M | $6.18M | $5.69M | $3.84M | $5.78M | $7.48M | $8.97M | $11.83M | $9.87M | $6.86M | $3.39M | |
| — | 32.33% | 26.46% | 29.84% | 25.16% | 26.65% | 30.92% | 31.66% | 31.95% | 28.89% | — | — | — | — | — | — | — | |
| $3.22M | $3.55M | $3.8M | $3.95M | $3.71M | $9.21M | $4.44M | $4.48M | $4.6M | $4.66M | $5.87M | $5.7M | $6.11M | $5.76M | $4.14M | $3.41M | $2.78M | |
| $57.94K | $59.87K | $23.31K | $48.09K | $51.11K | $72.73K | $86.28K | $99.1K | $74.6K | $107.68K | $312.56K | $357.46K | $377.2K | $344.52K | $321.73K | $320.86K | $321.71K | |
| -$154.94K | -$637.66K | -$1.29M | $1.12M | $1.17M | -$3.85M | $2.23M | $1.7M | -$1.26M | -$777.82K | -$91.76K | $1.78M | $2.86M | $6.07M | $5.73M | $3.45M | $609.89K | |
| — | -7.08% | -13.54% | 6.58% | 6.06% | -19.16% | 10.32% | 8.7% | -7.09% | -5.85% | — | — | — | — | — | — | — | |
| -$97.01K | -$577.8K | -$1.26M | $1.17M | $1.23M | -$3.78M | $2.31M | $1.8M | -$1.19M | -$670.14K | $220.8K | $2.14M | $3.24M | $6.42M | $6.06M | $3.77M | $931.6K | |
| — | — | — | — | — | — | — | — | — | — | — | $7344 | $7186 | $7213 | $7425 | $6605 | $5605 | |
| — | $37.53K | $245.82K | $320.08K | $0 | — | — | — | — | — | — | $18.81K | $5352 | $10.33K | $11.08K | $19.71K | $14.98K | |
| $423.94K | $543.4K | $532.14K | $570.08K | $13.42K | $1.98M | $64.46K | $526.57K | $435.53K | $43.75K | -$56.98K | $11.46K | $14.02K | $4596 | $22K | $11.78K | $11.3K | |
| $269K | -$94.26K | -$755.45K | $1.69M | $1.19M | -$1.88M | $2.29M | $2.22M | $1.52M | -$773.95K | -$203.74K | $1.79M | $2.88M | $6.08M | $5.76M | $3.46M | $621.19K | |
| $17.47K | $6203 | $22.17K | $377.31K | $181.68K | $213.25K | $239.09K | $135.99K | $2.79M | $3866 | $52.83K | $167.98K | $464.53K | $1.17M | $1.07M | $304.8K | $249.28K | |
| $251.53K | -$100.46K | -$777.62K | $1.31M | $1.01M | -$2.09M | $2.05M | $2.09M | $1.28M | -$1.41M | -$256.58K | $1.62M | $2.41M | $4.91M | $4.69M | $3.16M | $371.91K | |
| — | -1.12% | -8.18% | 7.72% | 5.19% | -10.39% | 9.51% | 10.7% | 7.19% | -10.64% | — | — | — | — | — | — | — | |
| $217.19K | -$84.8K | -$725.51K | $1.28M | $1.1M | -$2.11M | $2.07M | $2.12M | $1.25M | -$1.11M | -$195.91K | $1.53M | $2.35M | $4.92M | $4.62M | $3.16M | — | |
| USD/shares | -$0.11 | — | — | — | — | — | — | — | — | -$0.06 | -$0.01 | $0.07 | $0.11 | $0.22 | $0.23 | $0.15 | $0.02 |
| USD/shares | $0.01 | -$0.00 | -$0.03 | $0.06 | — | — | — | — | — | -$0.06 | -$0.01 | $0.07 | $0.10 | $0.21 | $0.20 | $0.14 | $0.02 |
| shares | — | 22.95M | 22.97M | 22.97M | 23M | 23.03M | 23M | 23.05M | 23.08M | 23.1M | 23.02M | 23.07M | 22.98M | 22.2M | 20.76M | 20.75M | 20.75M |
| shares | — | 22.96M | 22.97M | 23M | 23.03M | 23.16M | 23.04M | 23.11M | 23.1M | 23.1M | 23.19M | 23.4M | 23.69M | 23.66M | 22.94M | 22.55M | 22.38M |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2014–FY2025: $579.29K in buybacks, $12.07M in dividends.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-07-31 | USD 0 | 10-Q filed 2026-09-14 |
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 18 similar-size Health Information Services companies (of 52 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Puerto Rico Consulting | $4,636,857 | $5,690,166 | $8,038,143 | $12,142,278 | $14,680,665 | $18,214,656 |
| United States Consulting | $2,620,430 | $3,162,151 | $4,672,255 | $4,558,018 | $2,720,662 | $2,283,370 |
| Europe Consulting | $1,727,139 | $571,183 | $4,260,224 | $2,650,783 | $2,329,359 | $829,170 |
| Other Segment | $16,670 | $85,779 | $6,234 | $47,648 | $384,489 | $237,164 |